skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

8 Total results for product and free and sample content found

Pink Sheet

Six Pharma CEOs To Testify In House as Democrats, Trump Compete For Attention On Drug Pricing

US Election Drug Pricing Debate

While neither party is likely to make any big policy changes this year, the action from both sides of the aisle indicates politicians still see going after pharma as a winning issue with voters even as polls show voters are focused elsewhere.

Topic US Election 2020 Drug Pricing

Pink Sheet

'March In' Plan Unveiled By Democratic Think Tank: A Battle Biopharma Would Welcome?

Trump Biden US Elections

In sign of how much has changed in four years, industry might be better off if Biden takes CAP’s advice and launches ‘march-in’ actions to address pricing of COVID products.

Topic US Election 2020 Drug Pricing

Pink Sheet

Biden's Drug Pricing Administrative Actions Could Focus On Medicare Demos

Joe Biden Drug Pricing

Center for American Progress suggests pricing reforms for the 'next Administration' in lieu of legislation.

Topic US Election 2020 Drug Pricing

Pink Sheet

Biopharma Needs A Deal On Drug Pricing As Shield Against Possible Democrat Wins - BIO's Greenwood

US Election Drug Pricing Shielding

Outgoing Biotechnology Innovation Organization CEO suggests consideration of price inflation caps instead of 'big discounts' in Medicare Part D and says that industry should fund a cap on beneficiary out-of-pocket costs in the program.

Topic US Election 2020 Drug Pricing Legislation

Pink Sheet

Biopharma, the White House And Getting Drug Pricing 'Off The Table'

White House Drug Pricing

Industry balks at President Trump’s latest effort to force biopharma to negotiate a drug pricing solution, but investors may be pushing for concessions that could head off more onerous policies supported by a Biden White House.

Topic US Election 2020 Drug Pricing Regulation

Scrip, Pink Sheet

Drug Pricing Update: Strategies and Trends

Drug pricing update: strategies and trends

For vital coverage of critical issues in drug pricing worldwide, top organizations turn to expert insights from Scrip. Download your free Drug Pricing article pack to examine the current trends, strategies, and policies impacting businesses like yours. 

Topic Drug Pricing

Pink Sheet, Scrip

Top 5 Drug Pricing Insights and Policies

Top 5 drug pricing insights and policies

For vital coverage of critical issues in drug pricing worldwide, top organizations turn to expert insights from Pink Sheet. Download your free Drug Pricing article pack to examine the current trends, strategies, and policies impacting businesses like yours.

Topic Drug Pricing

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: